The Effect of the β2-Adrenoceptor Agonist Prodrug BRL-47672 on Cardiovascular Function, Skeletal Muscle Myosin Heavy Chain, and MyoD Expression in the Rat
Open Access
- 8 July 2004
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 311 (3), 1225-1231
- https://doi.org/10.1124/jpet.104.071589
Abstract
The intracellular mechanisms that regulate changes in postnatal myosin heavy chain (MHC) expression are not well established. The major objective of this study was to examine the acute and chronic effects of administration of BRL-47672, the prodrug of the β2-adrenoceptor agonist clenbuterol on MHC and MyoD transcription factor expression to determine whether or not changes in MHC composition are preceded by changes in MyoD protein expression. To assess to what extent the use of BRL-47672 minimized cardiovascular effects, its hemodynamic actions were compared with those of clenbuterol. The effect of BRL-47672 on heart rate, mean arterial blood pressure, and hindquarters vascular conductance was significantly less than that of clenbuterol after a single i.p. injection (250 μg kg-1 body mass). In the main study, 4-week old rats were given BRL-47672 (900 μg kg-1 body mass) or an equivalent volume of saline (control) daily for 1, 28, or 56 days. Soleus muscle (SOL) was excised and MHC and MyoD expression analyzed. After 4 weeks, SOL from the BRL-47672-treated animals had significantly faster MHC composition (49 ± 2% MHCIIA) compared with those from the control animal (39 ± 3% MHCIIA, P < 0.05). MyoD expression increased by 40% after 1 day of BRL-47672 administration (P < 0.05) before a change in MHC composition. In conclusion, these data suggest that increased expression of fast-type MHCIIA expression in rat SOL induced by BRL-47672 administration is preceded by changes in the level of MyoD transcription factor expression.Keywords
This publication has 27 references indexed in Scilit:
- Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious ratsBritish Journal of Pharmacology, 2002
- bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out.Genes & Development, 1994
- The MyoD family and myogenesis: Redundancy, networks, and thresholdsCell, 1993
- Alterations of skeletal muscle in chronic heart failure.Circulation, 1992
- Changes in myosin heavy‐chain isoform synthesis of chronically stimulated rat fast‐twitch muscleEuropean Journal of Biochemistry, 1992
- A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteinsCell, 1989
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences of the United States of America, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- THREE "MYOSIN ADENOSINE TRIPHOSPHATASE" SYSTEMS: THE NATURE OF THEIR pH LABILITY AND SULFHYDRYL DEPENDENCEJournal of Histochemistry & Cytochemistry, 1970